Trials / Unknown
UnknownNCT03634189
Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C
Phase I, Single Center, Open-label Study of Cannabidiol in Patients With Heart Failure in AHA/ACC Stages A-C
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud · Academic / Other
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Cannabidiol in heart failure
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol | Patients with ACC/AHA stage A-C will receive 5 mg/kg to a maximum tolerated dose of 25 mg/kg PO BID of Cannabidiol |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-09-01
- Completion
- 2021-12-01
- First posted
- 2018-08-16
- Last updated
- 2020-08-05
Source: ClinicalTrials.gov record NCT03634189. Inclusion in this directory is not an endorsement.